Olfactory Bioscience (OLFC) 0.0538 $OLFC OLFC's Special

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Olfactory Bioscience (OLFC) 0.0538 $OLFC

OLFC's Special Event: $19.95 for All Natural Non-Prescription Effective Medicines for Anxiety, Sleep, Sensory and Spectrum Issues
M2 - Mon Dec 14, 6:33AM CST
Olfactory Biosciences' Special Season One Month Only prices are 60% from regular $ 49.95PHILADELPHIA, PA / Olfactory Biosciences Corp. (OLFC) is pleased to offer its entire line of advanced natural medicines at a Special Season Price of $ 19.95. Applying topical medicine is just rubbing a small amount of the medicine gel to the end of your nostrils. Just in time for the holiday season so the consumer can have self-help for most ordinary conditions. https://www.noxoinfo.com

Special $19.95 Season Event for All OLFC's Natural Non-Prescription Effective Medicines for Anxiety, Sleep, Sensory and Spectrum Issues As Well As Other Common Conditions
ACCESSWIRE - Thu Dec 10, 2:01AM CST
Olfactory Biosciences' Special Season One Month Only prices are 60% from regular $ 49.95

Latest Medical Discovery from OLFC Lets You Whiff Your Hunger Cravings Away on Any Diet. Maintain Your Loss or Even Lose More with HungerMgmt(TM)
ACCESSWIRE - Thu May 07, 10:00AM CDT
HungerMgmt(TM) Combines the Best of All Worlds for Crushing Cravings and Stopping Overeating with Nanotechnology, Phytochemicals, Phytonutrients,Tyrosine and Dopamine; The Topical Non-prescription Preparation Can Be Used with Any Popular Diet or Your Own; The HungerMgmt(TM) Preparation is Made with Natural Ingredients, and is Effective by Using Advanced Olfaction and Chemoreception; Applying HungerMgmt(TM) is Just Rubbing a Small Amount of the Preparation to the End of Your Nostrils

Nightmares and Bad Dreams May Now Be Eliminated with NOXO from OLFC.
ACCESSWIRE - Mon Apr 20, 5:31AM CDT
American Sleep Association Noted that Nightmares are Extremely Common, and May Affect as Many As 80-90% of People at Some Point in Their Lives: NOXO Odor Defense Pro(TM) Can Eliminate This Problem; German Researchers at the Sleep Laboratory at the Central Institute of Mental Health in Mannheim, Germany Have Found That Sleepers Exposed to Unpleasant or Nauseating Odors During Sleep Experienced a Significant Number of Nightmares and Bad Dreams

OLFC Announced that Its Manufacturing Partner, FFS, has Kosher Certification
ACCESSWIRE - Fri Mar 27, 5:31AM CDT
PHILADELPHIA, PA / ACCESSWIRE / March 27, 2015 / Olfactory Biosciences Corp (PINKSHEETS:OLFC) is pleased to announce that its manufacturing partner FFS has Kosher Certification as well as an FDA approved facility. FFS has the superior technical expertise that is necessary to produce our products. We recognize that the combined talent and enthusiasm of FFS employees is one of our most valuable resources.

OLFC Announces Revolutionary Topical Non-Prescription Natural Medicines for Anxiety, Stress, Sensory issues and Other Common Conditions -- An Answer to Today's Health Care Debacle
PR Newswire - Thu Jan 15, 8:47AM CST
Olfactory Biosciences Corp. (OLFC) is pleased to announce 9 revolutionary New Age Medicines for 2015. The new products use natural ingredients, advanced Olfaction and chemoreception. Applying topical medicine is just rubbing a small amount of the medicine balm to the end of your nostrils.

OLFC Announces Innovative New Age Topical Non-Prescription Natural Medicines For Common Conditions. An Answer to Today's Health Care Debacle
ACCESSWIRE - Fri Jan 09, 5:30AM CST
CONSUMER HEAL THYSELF Now is the time when consumers must stop acting like meek victims of government health care plans and take charge. The New Age of Medicine is all about CONSUMER HEAL THYSELF. Olfactory Biosciences is just in time to deliver affordable and non-prescription natural medicines so that the consumer can, in fact, have self-help medicine for most common conditions

OLFC Puts You in a Great Mood for the Holidays
ACCESSWIRE - Tue Dec 09, 5:02AM CST
Philadelphia, PA / ACCESSWIRE / December 9, 2014 / Olfactory Biosciences Corp (OLFC) is pleased to announce a special Holiday Edition of NOXO Mood Boost. The improved NOXO "New Age Medicine" product uses natural ingredients, advanced olfaction and chemoreception and no aromatherapy. Applying topical NOXO is just rubbing a small amount of the balm to the end of your nostrils.

Autism, ADHD, Asperger's Syndrome, Brain & Nervous System, Behavioral issues, Mental Health and Rett Syndrome Helped with NOXO Topical Meds. OLFC Announces Up to 50% Discount until Dec 15, 2014
ACCESSWIRE - Thu Nov 20, 5:01AM CST
PHILADELPHIA, PA /ACCESSWIRE / November 20, 2014 / Olfactory Biosciences Corp (OTC : OLFC) is pleased to announce one month discounts on new cutting edge Next Generation Meds that use natural ingredients, advanced Olfaction and chemoreception. Applying NOXO is just rubbing a small amount of the balm to the end of your nostrils. www.noxoinfo.com

OLFC Announces Next Generation NOXO Alternative Medical Products Lineup for 2015 using Natural Ingredients and Advanced Olfaction and Chemoreception
ACCESSWIRE - Mon Nov 10, 5:01AM CST
Philadelphia, PA / ACCESSWIRE / November 10, 2014 / Olfactory Biosciences Corp (OTC: OLFC ) is pleased to announce 9 new cutting edge Next Generation Alternative Wellness products for 2015. The improved NOXO products use natural ingredients, advanced Olfaction and chemoreception. Applying topical NOXO is just rubbing a small amount of the balm to the end of your nostrils. www.noxoinfo.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

YouTube Shuts Down Tenet Media Channel Amid Legal Issues

Updated Category News Views 305

YouTube's Action Against Tenet Media Explained YouTube, which is part of Alphabet (NASDAQ: GOOGL), has made a significant move by shutting down the Tenet Media channel, along with four other channels managed by Lauren Chen. This decision comes in response to serious legal actions taken by the U.S. Department of Justice against certain individuals involved in money...

Continue Reading
Ardelyx Faces Class Action Lawsuit Amidst Investment Losses

Updated Category News Views 112

Important Update for Ardelyx Investors Regarding Class Action Pomerantz LLP has recently informed shareholders about a class action lawsuit involving Ardelyx, Inc. This lawsuit targets both the company and its key officers, alleging violations of federal securities laws. Investors who held Ardelyx securities during a specified timeframe should pay close attention to this...

Continue Reading
Derek Bryson Park: Innovator Transforming Finance Worldwide

Updated Category News Views 205

Celebrating Derek Bryson Park's Impact on Finance Derek Bryson Park has recently been highlighted by The Enterprise World Magazine as a key figure in the financial industry, a well-deserved recognition for his extensive and impactful career. With three decades of experience, Park continues to innovate in finance, public service, and global diplomacy. Pioneering Leadership...

Continue Reading
Understanding Currency Impacts in Global Trade Dynamics

Updated Category News Views 291

Understanding Currency Impacts in Global Trade Dynamics Scott Bessent, a noted figure in finance, is igniting conversations regarding tariffs and trade in recent discussions. All eyes on Wall Street are focused on how these changes influence market dynamics. Initially, any reduction in the U.S. trade deficit with other nations may seem like a significant win for the...

Continue Reading
Pennant Group Expands Its Operations with Recent Acquisition

Updated Category News Views 283

Pennant Group's Strategic Acquisition Announcement The Pennant Group, Inc. (NASDAQ: PNTG), a prominent holding company in the healthcare industry, recently achieved a significant milestone by acquiring specific operational assets from UnitedHealth Group Incorporated. This notable transaction was made possible due to UnitedHealth’s acquisition of Amedisys Inc., enabling...

Continue Reading